Not Yet Recruiting
A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of mRNA-1469 Vaccine to Prevent Ebola-Bundibugyo Virus Disease in Healthy Adult Participants
NCT07737717
- Conditions
- Ebola-Bundibugyo Virus Disease (Ebola-BDBV)
- Locations
-
- Canadian Center for Vaccinology Halifax, Nova Scotia, Canada
- Colchester Research Group Truro, Nova Scotia, Canada
- Centricity Research Toronto LMC Multispecialty Toronto, Ontario, Canada